Patents Assigned to Kiadis Pharma Canada Inc.
  • Halogenated rhodamine derivatives and applications thereof
    Patent number: 9636363
    Abstract: Methods for treating an infection in a tissue sample are described. Tissue samples that are harvested from a patient may be infected with either bacteria or a virus. A rhodamine compound is mixed with the infected tissue sample to form a mixture. The mixture is then exposed to radiant energy to inhibit or kill the bacteria. The exposed mixture is then transplanted into the patient. The rhodamine compounds may be 2?-(6-dimethylamino-3-dimethylimino-3H-xanthen-9-yl) 4?, 5?-dichloro-benzoic acid methyl ester hydrochloride.
    Type: Grant
    Filed: January 28, 2013
    Date of Patent: May 2, 2017
    Assignee: Kiadis Pharma Canada Inc.
    Inventors: Abdelkrim Habi, Denis Gravel, Luc Villeneuve, Hongsheng Su, Marc Vaillancourt
  • Halogenated rhodamine derivatives and applications thereof
    Patent number: 8383672
    Abstract: Methods for treating a bacterial infection in a tissue sample are described. Tissue samples that are harvested from a patient may be infected with bacteria. A rhodamine compound is mixed with the infected tissue sample to form a mixture. The mixture is then exposed to radiant energy to inhibit or kill the bacteria. The exposed mixture is then transplanted into the patient.
    Type: Grant
    Filed: June 9, 2011
    Date of Patent: February 26, 2013
    Assignee: Kiadis Pharma Canada Inc.
    Inventors: Abdelkrim Habi, Denis Gravel, Luc Villeneuve, Hongsheng Su, Marc Vaillancourt
  • HALOGENATED RHODAMINE DERIVATIVES AND APPLICATIONS THEREOF
    Publication number: 20110021616
    Abstract: Methods for treating a bacterial infection in a tissue sample are described. Tissue samples that are harvested from a patient may be infected with bacteria. A rhodmaine compound is mixed with the infected tissue sample to form a mixture. The mixture is then exposed to radiant energy to inhibit or kill the bacteria. The exposed mixture is then transplanted into the patient.
    Type: Application
    Filed: May 24, 2010
    Publication date: January 27, 2011
    Applicant: KIADIS PHARMA CANADA INC.
    Inventors: ABDELKRIM HABI, DENIS GRAVEL, LUC VILLENEUVE, HONGSHENG SU, MARC VAILLANCOURT